Sintx Technologies, Inc. (SINT)
USD 2.01
(-19.6%)
USD 2.01
(-19.6%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.25 Million USD | 49.91% |
| 2022 | -16.48 Million USD | -67.86% |
| 2021 | -9.82 Million USD | -34.32% |
| 2020 | -7.31 Million USD | -50.81% |
| 2019 | -4.84 Million USD | 43.96% |
| 2018 | -8.65 Million USD | 7.26% |
| 2017 | -9.32 Million USD | 43.79% |
| 2016 | -16.59 Million USD | 30.59% |
| 2015 | -23.91 Million USD | 26.61% |
| 2014 | -32.58 Million USD | -293.22% |
| 2013 | -8.28 Million USD | 76.35% |
| 2012 | -35.03 Million USD | -47.51% |
| 2011 | -23.75 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -886 Thousand USD | 61.83% |
| 2024 Q2 | -2.2 Million USD | -148.76% |
| 2023 Q4 | -2.32 Million USD | 27.24% |
| 2023 FY | -8.25 Million USD | 49.91% |
| 2023 Q1 | 2.96 Million USD | 135.31% |
| 2023 Q2 | -2.45 Million USD | -182.69% |
| 2023 Q3 | -3.19 Million USD | -29.94% |
| 2022 Q1 | -2.81 Million USD | -75.63% |
| 2022 Q2 | -2.24 Million USD | 20.25% |
| 2022 Q3 | -2.65 Million USD | -18.47% |
| 2022 Q4 | -8.4 Million USD | -216.69% |
| 2022 FY | -16.48 Million USD | -67.86% |
| 2021 Q3 | -2.34 Million USD | -6.55% |
| 2021 Q1 | -2.63 Million USD | -51.93% |
| 2021 Q2 | -2.19 Million USD | 16.48% |
| 2021 FY | -9.82 Million USD | -34.32% |
| 2021 Q4 | -1.6 Million USD | 31.71% |
| 2020 FY | -7.31 Million USD | -50.81% |
| 2020 Q1 | 1.16 Million USD | 217.84% |
| 2020 Q2 | -4.02 Million USD | -444.57% |
| 2020 Q3 | -2.43 Million USD | 39.5% |
| 2020 Q4 | -1.73 Million USD | 28.89% |
| 2019 Q2 | -730 Thousand USD | 55.19% |
| 2019 Q4 | -992 Thousand USD | 31.4% |
| 2019 FY | -4.84 Million USD | 43.96% |
| 2019 Q1 | -1.62 Million USD | -632.35% |
| 2019 Q3 | -1.44 Million USD | -98.08% |
| 2018 Q1 | -3.39 Million USD | -50.46% |
| 2018 FY | -8.65 Million USD | 7.26% |
| 2018 Q3 | -3.24 Million USD | -40.44% |
| 2018 Q4 | 306 Thousand USD | 109.42% |
| 2018 Q2 | -2.31 Million USD | 31.98% |
| 2017 Q1 | -2.15 Million USD | 43.54% |
| 2017 FY | -9.32 Million USD | 43.79% |
| 2017 Q4 | -2.25 Million USD | 19.75% |
| 2017 Q3 | -2.81 Million USD | -33.67% |
| 2017 Q2 | -2.1 Million USD | 2.05% |
| 2016 Q1 | -3.38 Million USD | -37.44% |
| 2016 FY | -16.59 Million USD | 30.59% |
| 2016 Q4 | -3.8 Million USD | 12.22% |
| 2016 Q2 | -5.06 Million USD | -49.47% |
| 2016 Q3 | -4.33 Million USD | 14.34% |
| 2015 FY | -23.91 Million USD | 26.61% |
| 2015 Q4 | -2.46 Million USD | 75.67% |
| 2015 Q3 | -10.13 Million USD | -70.79% |
| 2015 Q2 | -5.93 Million USD | -10.26% |
| 2015 Q1 | -5.38 Million USD | 44.51% |
| 2014 Q1 | -4.71 Million USD | -811.62% |
| 2014 FY | -32.58 Million USD | -293.22% |
| 2014 Q4 | -9.69 Million USD | -96.63% |
| 2014 Q3 | -4.93 Million USD | 62.75% |
| 2014 Q2 | -13.23 Million USD | -180.9% |
| 2013 Q1 | -3.53 Million USD | 85.47% |
| 2013 Q3 | -2.34 Million USD | 23.42% |
| 2013 Q4 | 662.29 Thousand USD | 128.21% |
| 2013 Q2 | -3.06 Million USD | 13.24% |
| 2013 FY | -8.28 Million USD | 76.35% |
| 2012 Q3 | -2.67 Million USD | 0.0% |
| 2012 FY | -35.03 Million USD | -47.51% |
| 2012 Q4 | -24.32 Million USD | -808.46% |
| 2011 FY | -23.75 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 86.596% |
| BrainsWay Ltd. | -4.19 Million USD | -96.783% |
| Cerus Corporation | -37.48 Million USD | 77.97% |
| Envoy Medical, Inc. | -29.9 Million USD | 72.385% |
| electroCore, Inc. | -18.83 Million USD | 56.148% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 6.678% |
| IceCure Medical Ltd | -14.65 Million USD | 43.632% |
| Inogen, Inc. | -102.44 Million USD | 91.938% |
| OrthoPediatrics Corp. | -20.97 Million USD | 60.623% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 84.318% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 39.914% |
| MaxCyte, Inc. | -37.92 Million USD | 78.222% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 30.36% |
| Nexalin Technology, Inc. | -4.64 Million USD | -77.662% |
| Orthofix Medical Inc. | -151.39 Million USD | 94.545% |
| PAVmed Inc | -64.17 Million USD | 87.131% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 84.259% |
| RxSight, Inc. | -48.6 Million USD | 83.009% |
| Sight Sciences, Inc. | -55.54 Million USD | 85.132% |
| SI-BONE, Inc. | -43.33 Million USD | 80.942% |
| TELA Bio, Inc. | -46.66 Million USD | 82.301% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 83.324% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 39.196% |
| Acutus Medical, Inc. | -81.66 Million USD | 89.886% |
| Talis Biomedical Corporation | -62 Million USD | 86.681% |
| Spectral AI, Inc. | -20.85 Million USD | 60.396% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 86.411% |
| CVRx, Inc. | -41.19 Million USD | 79.953% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1390.074% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 24.612% |
| Bioventus Inc. | -156.23 Million USD | 94.714% |
| Venus Concept Inc. | -37.25 Million USD | 77.828% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 86.011% |
| LivaNova PLC | 17.54 Million USD | 147.071% |
| 908 Devices Inc. | -36.39 Million USD | 77.31% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 95.575% |
| Nemaura Medical Inc. | -14.14 Million USD | 41.607% |
| NeuroPace, Inc. | -32.95 Million USD | 74.939% |
| LENSAR, Inc. | -14.38 Million USD | 42.578% |
| Apyx Medical Corporation | -18.71 Million USD | 55.865% |
| Cutera, Inc. | -162.83 Million USD | 94.928% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 23.74% |
| BioSig Technologies, Inc. | -29.04 Million USD | 71.561% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 90.009% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 62.61% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 112.192% |
| Axonics, Inc. | -6.08 Million USD | -35.66% |
| Outset Medical, Inc. | -172.79 Million USD | 95.22% |
| IRIDEX Corporation | -9.57 Million USD | 13.699% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 92.201% |
| IRadimed Corporation | 17.19 Million USD | 148.038% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -0.182% |
| INVO Bioscience, Inc. | -8.03 Million USD | -2.793% |
| Telesis Bio, Inc. | -47.72 Million USD | 82.694% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 180.631% |
| Varex Imaging Corporation | -47.7 Million USD | 82.686% |
| Quipt Home Medical Corp. | -2.78 Million USD | -196.659% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 26.821% |
| Pulmonx Corporation | -60.84 Million USD | 86.426% |
| Dynatronics Corporation | -2.69 Million USD | -206.148% |
| Modular Medical, Inc. | -17.47 Million USD | 52.725% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 27.47% |
| Semler Scientific, Inc. | 20.58 Million USD | 140.125% |
| InMode Ltd. | 197.91 Million USD | 104.173% |
| Bruker Corporation | 427.2 Million USD | 101.933% |
| Cytosorbents Corporation | -28.5 Million USD | 71.029% |
| DexCom, Inc. | 541.5 Million USD | 101.525% |
| Align Technology, Inc. | 445.05 Million USD | 101.856% |
| Viveve Medical, Inc. | -22.02 Million USD | 62.505% |
| ZimVie Inc. | -393.28 Million USD | 97.9% |
| Movano Inc. | -29.28 Million USD | 71.796% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 32.014% |
| Nexalin Technology, Inc. | -4.64 Million USD | -77.662% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1390.074% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 96.29% |
| Profound Medical Corp. | -28.56 Million USD | 71.091% |
| Insulet Corporation | 206.3 Million USD | 104.003% |
| enVVeno Medical Corporation | -23.51 Million USD | 64.879% |
| Surmodics, Inc. | -11.54 Million USD | 28.444% |
| iCAD, Inc. | -4.84 Million USD | -70.394% |
| Nuwellis, Inc. | -20.2 Million USD | 59.132% |
| Biotricity, Inc. | -14.09 Million USD | 41.402% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 93.307% |
| Aethlon Medical, Inc. | -12.2 Million USD | 32.349% |
| InspireMD, Inc. | -19.91 Million USD | 58.531% |
| PAVmed Inc. | -64.17 Million USD | 87.131% |
| BIOLASE, Inc. | -20.63 Million USD | 59.97% |
| Beyond Air, Inc. | -60.24 Million USD | 86.29% |
| FONAR Corporation | 10.56 Million USD | 178.155% |
| AxoGen, Inc. | -21.71 Million USD | 61.968% |
| Vivani Medical, Inc. | -25.65 Million USD | 67.804% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 128.964% |
| Inari Medical, Inc. | -1.63 Million USD | -404.829% |
| UFP Technologies, Inc. | 44.92 Million USD | 118.384% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -60.921% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -25.038% |
| Tenon Medical, Inc. | -15.58 Million USD | 46.993% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 46.461% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 76.625% |
| AdaptHealth Corp. | -678.89 Million USD | 98.783% |
| NanoVibronix, Inc. | -3.71 Million USD | -122.555% |
| Quanterix Corporation | -32.33 Million USD | 74.457% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 26.821% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1802.887% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 97.307% |
| TransMedics Group, Inc. | -25.02 Million USD | 67.001% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 62.685% |
| NeuroMetrix, Inc. | -6.52 Million USD | -26.488% |
| Hyperfine, Inc. | -44.23 Million USD | 81.331% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 89.479% |
| Biomerica, Inc. | -5.97 Million USD | -38.157% |
| Bone Biologics Corporation | -8.94 Million USD | 7.708% |
| AVITA Medical, Inc. | -39.16 Million USD | 78.914% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 17.027% |
| Silk Road Medical, Inc | -55.74 Million USD | 85.184% |